Palatal donor site wound after free gingival graft surgery.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients eligible for FGG surgical treatment Systemically healthy patients Age between 18 and 60 years No medications affecting the inflammatory response or wound healing (such as corticosteroids, Non-Steroidal Anti-Inflammatory Drug: NSAIDs, or immunosuppressive drugs within the last 1 month) No history of periodontal surgery in the donor area within the last 6 months Written informed consent to participate in the study Patients with no history of smoking Patients with no systemic conditions affecting wound healing
Exclusion criteria
Exclusion criteria: Pregnant patients or lactating mothers Patient non-cooperation in follow-ups or failure to attend 14-day visit Change in patient's systemic or drug conditions that may affect study results Patients with uncontrolled systemic conditions Patients with bleeding disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Immediately after surgery and 14 days after surgery. Method of measurement: Visual Analogue Scale.;Wound Healing. Timepoint: 14 days after surgery. Method of measurement: Wound Healing Index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory biomarker IL-1ß in saliva. Timepoint: Before surgery and 14 days after surgery. Method of measurement: enzyme-linked immunosorbent assay (ELISA).;Anti-inflammatory biomarker IL-10 in saliva. Timepoint: Before surgery and 14 days after surgery. Method of measurement: enzyme-linked immunosorbent assay (ELISA). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences